Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Research
Blocking enzyme saved mice from known Parkinson’s mechanism
Several companies, like Denali Therapeutics and Neuron23, are targeting the mechanism in phase 2 trials.
Darren Incorvaia
Jul 2, 2025 5:26pm
Shionogi offers $600M for Swiss biotech's antibiotic program
Jul 2, 2025 1:00am
Pfizer expands XtalPi small-molecule discovery collab
Jun 30, 2025 10:00am
Arialys presents promising data for IgG1 antibody treatment
Jun 20, 2025 5:02am
Federal judge rules hundreds of NIH grant terminations unlawful
Jun 16, 2025 5:55pm
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Jun 16, 2025 1:07pm
